Reports of randomised clinical trials normally raise debate among practitioners and a flock of correspondence to medical journals. Two recent reports from the Standard and New Antiepileptic Drugs (SANAD) trial published in The Lancet were no exception. In this case, the trial's conclusions have been particularly challenged by paediatric specialists. The reason for their concern is that the trial included children over 4 years of age and adolescents, yet subgroup analyses for these specific popul Join discussion...

NEUROLOGY - Medical Reference Join discussion...